SB202190 (FHPI)
产品编号 | 产品名称 | 包装规格 | 价格 |
C152121 | SB202190 (FHPI) | 50mg | 1440 |
产品介绍
Background | SB202190 is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively. SB 202190 binds to the ATP pocket of the active recombinant human p38 kinase with a Kd of 38 nM. SB 202190 has anti-cancer activity and rescued memory deficits. SB202190 induces autophagy. | ||
M. W t | 331.34 | ||
Formula | C20H14FN3O | ||
CAS No | |||
Storage | Powder | - 20°C | 3 years |
4°C | 2 year C20H14FN3O | ||
In solvent | -80°C | 6 months | |
-20°C | 1 month | ||
Solubility | DMSO | 100 mg/mL(301.80 mM; Need ultrasonic) | |
Ethanol | 12 mg/mL(36.22 mM) | ||
H2O | < 0.1 mg/mL(insoluble) | ||